Other

U.S. federal statutory tax

Insmed U.S. federal statutory tax remained flat by 0.0% to -$66.77M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 39.7%, from -$47.78M to -$66.77M. Over 2 years (FY 2023 to FY 2025), U.S. federal statutory tax shows a downward trend with a 30.5% CAGR.

Analysis

StatementCash Flow Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Provides a benchmark to evaluate the impact of tax credits, deductions, and other adjustments on the actual tax paid.

Detailed definition

Represents the theoretical federal income tax expense calculated by applying the statutory federal tax rate to the compa...

Peer comparison

Standard baseline for all U.S. corporations.

Metric ID: other_income_tax_reconciliation_income_tax_expense_benef_99b1bf

Historical Data

3 years
 FY'23FY'24FY'25
Value-$156.87M-$191.11M-$267.07M
YoY Change—-21.8%-39.7%
Range-$267.07M – -$156.87M
CAGR+30.5%
Avg YoY Growth-30.8%
Median YoY Growth-30.8%
Current Streak2+ years decline

Frequently Asked Questions

What is Insmed's u.s. federal statutory tax?
Insmed (INSM) reported u.s. federal statutory tax of -$66.77M in Q4 2025.
How has Insmed's u.s. federal statutory tax changed year-over-year?
Insmed's u.s. federal statutory tax decreased by 39.7% year-over-year, from -$47.78M to -$66.77M.
What is the long-term trend for Insmed's u.s. federal statutory tax?
Over 2 years (2023 to 2025), Insmed's u.s. federal statutory tax has grown at a 30.5% compound annual growth rate (CAGR), from -$156.87M to -$267.07M.
What does u.s. federal statutory tax mean?
The baseline federal tax expense calculated using the standard statutory rate.